We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00064129
Recruitment Status : Active, not recruiting
First Posted : July 9, 2003
Last Update Posted : March 5, 2018
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : January 10, 2011
  Study Completion Date : No date given